Avoro Capital Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
A detailed history of Avoro Capital Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 11,111,111 shares of ARWR stock, worth $221 Million. This represents 3.04% of its overall portfolio holdings.
Number of Shares
11,111,111
Previous 8,888,888
25.0%
Holding current value
$221 Million
Previous $172 Million
21.38%
% of portfolio
3.04%
Previous 2.59%
Shares
9 transactions
Others Institutions Holding ARWR
# of Institutions
305Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$312 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$242 Million0.0% of portfolio
-
State Street Corp Boston, MA6.02MShares$120 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$104 Million1.89% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$58.8 Million0.0% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.11B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...